Novus is focused on using the world’s leading innovative technology platform to build a globally competitive pipeline of anti-infective, critical care and pediatric medicine. Product dosage forms include:sterile powder injection, sterile liquid injection, hard capsule, tablet (quick release, slow release, controlled release), soft capsule, etc.

    Novus aspires to be the leader in the global pharma industry as an innovation driven organization focused on our inherent strengths in advanced science. We aim to develop a potent product pipeline of affordable medicines by using the leading innovative technology platform, such as Nanotechnology and sustained release technology, primarily of anti-infective, anti-tumor and cardiovascular drugs.

Novus was recognized as a national high-tech enterprise in 2020. It is a science and technology oriented small and medium-sized enterprise, water-saving enterprise, innovative small and medium-sized enterprise, and a "specialized, refined, unique, and new" small and medium-sized enterprise in Zhejiang Province. It is also the research and development center for innovative biopharmaceutical preparations and health products high-tech enterprises in the province. It is an advanced manufacturing enterprise and excellent member unit of the Zhejiang Health and Beauty Industry Association in 2018, an activity base for the Yangtze River Delta Nutrition and Health Food Innovation Factory, one of the first pilot demonstration enterprises in Shaoxing City to connect to the "Zhejiang Food Chain", and a harmonious labor relationship enterprise in Shaoxing City.

Novus has completed the transformation of more than 20 scientific and technological achievements, and has three types of products including drugs, health food, and food. It has launched 50 products and has a batch of products under research.

In January 2023, vancomycin hydrochloride for injection obtained FDA approval with an NDA of 505 (b) (2) and the health product obtained ISO22000 system certification, US dietary supplement cGMP system (NSF) certification and FSSC 22000 food safety management system certification.

Novus has a strong team with more than 400 members, and up to 70% of them are highly regarded experts in their fields. The workforce of Novus is composed of energetic and dynamic young talents that blends professional knowledge, relevant expertise and global industry experience. They strive for excellence in quality to ensure the delivery of high standard products. Key members of each team have rich and varied experience in EU, US, national and international markets in the area of Drug product development, manufacturing and quality management system. In addition, by virtue of the well-established cGMP system and the coporate culture with humanistic care, Novus attracts and cultivates lots of young and excellent qualified professionals with technique and management skills.